Germinal peptide eye drop promotes corneal epithelial and stromal defect healing in rabbit model

References

• Katzman LR, Jeng BH. Management strategies for persistent epithelial defects of the cornea. Saudi J Ophthalmol. 2014;28(3):168–172. doi:10.1016/j.sjopt.2014.06.011.
   PubMedGoogle Scholar
• Dunn SP, Heidemann DG, Chow CY, et al. Treatment of chronic nonhealing neurotrophic corneal epithelial defects with thymosin beta4. Ann N Y Acad Sci. 2010;1194(1):199–206. doi:10.1111/j.1749-6632.2010.05471.x.
   PubMedGoogle Scholar
• Al-Saleh GS, Alfawaz AM. Management of traumatic corneal abrasion by a sample of practicing ophthalmologists in Saudi Arabia. Saudi J Ophthalmol. 2018;32(2):105–109. doi:10.1016/j.sjopt.2017.10.007.
   PubMed Web of Science ®Google Scholar
• Suarez-Barrio C, Etxebarria J, Hernaez-Moya R, et al. Hyaluronic acid combined with serum rich in growth factors in corneal epithelial defects. Int J Mol Sci. 2019;20(7):1655. doi:10.3390/ijms20071655.
   PubMed Web of Science ®Google Scholar
• Nagai N, Iwai Y, Deguchi S, et al. Therapeutic potential of a combination of magnesium hydroxide nanoparticles and sericin for epithelial corneal wound healing. Nanomaterials (Basel). 2019;9(5):768. doi:10.3390/nano9050768.
   PubMedGoogle Scholar
• Liu CY, Kao WW. Corneal epithelial wound healing. Prog Mol Biol Transl Sci. 2015;134:61–71.
   PubMed Web of Science ®Google Scholar
• Goldstein AL, Slater FD, White A. Preparation, assay, and partial purification of a thymic lymphocytopoietic factor (thymosin). Proc Natl Acad Sci U S A. 1966;56(3):1010–1017. doi:10.1073/pnas.56.3.1010.
   PubMed Web of Science ®Google Scholar
• Goldstein AL, Hannappel E, Kleinman HK. Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues. Trends Mol Med. 2005;11(9):421–429. doi:10.1016/j.molmed.2005.07.004.
   PubMed Web of Science ®Google Scholar
• Cha HJ, Philp D, Lee SH, Moon HS, Kleinman HK, Nakamura T. Over-expression of thymosin beta 4 promotes abnormal tooth development and stimulation of hair growth. Int J Dev Biol. 2010;54(1):135–140. doi:10.1387/ijdb.082735hc.
   PubMed Web of Science ®Google Scholar
• Reti R, Kwon E, Qiu P, Wheater M, Sosne G. Thymosin beta4 is cytoprotective in human gingival fibroblasts. Eur J Oral Sci. 2008;116(5):424–430. doi:10.1111/j.1600-0722.2008.00569.x.
   PubMed Web of Science ®Google Scholar
• Sosne G, Kleinman HK. Primary mechanisms of thymosin β4 repair activity in dry eye disorders and other tissue injuries. Invest Ophthalmol Vis Sci. 2015;56(9):5110–5117. doi:10.1167/iovs.15-16890.
   PubMed Web of Science ®Google Scholar
• Jh-c H. Protection of thymosin beta-4 on corneal endothelial cells from UVB-induced apoptosis. Chin J Physiol. 2010;53(4):190–195. doi:10.4077/CJP.2010.AMH091.
   PubMedGoogle Scholar
• Sosne G, Rimmer D, Kleinman HK, Ousler G. Thymosin beta 4: a potential novel therapy for neurotrophic keratopathy, dry eye, and ocular surface diseases. Vitam Horm. 2016;102:277–306.
   PubMed Web of Science ®Google Scholar
• Carion TW, Ebrahim AS, Kracht D, et al. Thymosin beta-4 and ciprofloxacin adjunctive therapy improves pseudomonas aeruginosa-induced keratitis. Cells. 2018;7(10):145. doi:10.3390/cells7100145.
   PubMed Web of Science ®Google Scholar
• Sosne G, Kim C, Kleinman HK. Thymosin β4 significantly reduces the signs of dryness in a murine controlled adverse environment model of experimental dry eye. Expert Opin Biol Ther. 2015;Suppl 15(sup1):S155–161. doi:10.1517/14712598.2015.1019858.
   Google Scholar
• Ho JH, Chuang CH, Ho CY, Shih YR, Lee OK, Su Y. Internalization is essential for the antiapoptotic effects of exogenous thymosin beta-4 on human corneal epithelial cells. Invest Ophthalmol Vis Sci. 2007;48(1):27–33. doi:10.1167/iovs.06-0826.
   PubMed Web of Science ®Google Scholar
• Yuan H, Ma C, Moinet L, Sato N, Martins-Green M. Reversal of second-hand cigarette smoke-induced impairment of corneal wound healing by thymosin beta4 combined with anti-inflammatory agents. Invest Ophthalmol Vis Sci. 2010;51(5):2424–2435. doi:10.1167/iovs.09-3692.
   PubMed Web of Science ®Google Scholar
• Sosne G, Qiu P, Kurpakus-Wheater M, Matthew H. Thymosin beta4 and corneal wound healing: visions of the future. Ann N Y Acad Sci. 2010;1194(1):190–198. doi:10.1111/j.1749-6632.2010.05472.x.
   PubMedGoogle Scholar
• Sosne G, Chan CC, Thai K, et al. Thymosin beta 4 promotes corneal wound healing and modulates inflammatory mediators in vivo. Exp Eye Res. 2001;72(5):605–608. doi:10.1006/exer.2000.0985.
   PubMed Web of Science ®Google Scholar
• Thymosin beta 4 Suppression of Corneal NFκB A Potential AntiInflammatory Pathwa.pdf.
   Google Scholar
• Wang YY, Zhu QS, Wang YW, Yin RF. Thymosin beta-4 recombinant adeno-associated virus enhances human nucleus pulposus cell proliferation and reduces cell apoptosis and senescence. Chin Med J (Engl). 2015;128(11):1529–1535. doi:10.4103/0366-6999.157686.
   PubMed Web of Science ®Google Scholar
• Qiu P, Kurpakus-Wheater M, Sosne G. Matrix metalloproteinase activity is necessary for thymosin beta 4 promotion of epithelial cell migration. J Cell Physiol. 2007;212(1):165–173. doi:10.1002/jcp.21012.
   PubMed Web of Science ®Google Scholar
• Sosne G. Thymosin beta 4 and the eye: the journey from bench to bedside. Expert Opin Biol Ther. 2018;18(sup1):99–104. doi:10.1080/14712598.2018.1486818.
   PubMed Web of Science ®Google Scholar
• Philp D, Badamchian M, Scheremeta B, Nguyen M, Goldstein AL, Kleinman HK. Thymosin β 4 and a synthetic peptide containing its actin-binding domain promote dermal wound repair in db/db diabetic mice and in aged mice. Wound Repair Regen. 2003;11(1):19–24. doi:10.1046/j.1524-475X.2003.11105.x.
   PubMed Web of Science ®Google Scholar
• Philp D, Huff T, Gho YS, Hannappel E, Kleinman HK. The actin binding site on thymosin β 4 promotes angiogenesis. FASEB J. 2003;17(14):2103–2105. doi:10.1096/fj.03-0121fje.
   PubMedGoogle Scholar
• Holland EJ, Chan CC, Wetzig RP, Palestine AG, Nussenblatt RB. Clinical and immunohistologic studies of corneal rejection in the rat penetrating keratoplasty model. Cornea. 1991;10(5):374–380. doi:10.1097/00003226-199109000-00003.
   PubMed Web of Science ®Google Scholar
• Sosne G, Xu L, Prach L, et al. Thymosin beta 4 stimulates laminin-5 production independent of TGF-beta. Exp Cell Res. 2004;293(1):175–183. doi:10.1016/j.yexcr.2003.09.022.
   PubMed Web of Science ®Google Scholar
• Ho JH, Tseng KC, Ma WH, Chen KH, Lee OK, Su Y. Thymosin beta-4 upregulates anti-oxidative enzymes and protects human cornea epithelial cells against oxidative damage. Br J Ophthalmol. 2008;92(7):992–997. doi:10.1136/bjo.2007.136747.
   PubMed Web of Science ®Google Scholar
• Sosne G, Qiu P, Goldstein AL, Wheater M. Biological activities of thymosin ß 4 defined by active sites in short peptide sequences. FASEB J. 2010;24(7):2144–2151. doi:10.1096/fj.09-142307.
   PubMed Web of Science ®Google Scholar
• Wang L, Wu X, Shi T, Lu L. Epidermal growth factor (EGF)-induced corneal epithelial wound healing through nuclear factor κB subtype-regulated CCCTC binding factor (CTCF) activation. J Biol Chem. 2013;288(34):24363–24371. doi:10.1074/jbc.M113.458141.
   PubMed Web of Science ®Google Scholar
• Sosne G, Christopherson PL, Barrett RP, Fridman R. Thymosin-beta4 modulates corneal matrix metalloproteinase levels and polymorphonuclear cell infiltration after alkali injury. Invest Ophthalmol Vis Sci. 2005;46(7):2388–2395. doi:10.1167/iovs.04-1368.
   PubMed Web of Science ®Google Scholar
• Hwang D, MJ K, MJ J, Yb S, NG P, Gd K. Anti-inflammatory activity of β-thymosin peptide derived from pacific oyster (Crassostrea gigas) on NO and PGE₂ production by down-regulating NF-κB in LPS-induced RAW264.7 macrophage cells. Mar Drugs. 2019;17:129.
   PubMed Web of Science ®Google Scholar
• Zhang W, Nie L, Du L, Chen W, Wu Z, Jin Y. Topical treatment of corneal alkali burns with Gly-thymosin β(4) solutions and in situ hydrogels via inhibiting corneal neovascularization and improving corneal epidermal recovery in experimental rabbits. Burns. 2017;43(8):1742–1747. doi:10.1016/j.burns.2017.05.002.
   PubMed Web of Science ®Google Scholar